Practical vs Recent Clinical Trial Use Of Dalbavancin - Top-Institutions - MDSpire

Practical vs Recent Clinical Trial Use Of Dalbavancin

  • By

  • Sarah A. Uhm

  • Bryan T. Alexander

  • Elizabeth R. Lyden

  • Nicolas Cortes-Penfield

  • Harlan R. Sayles

  • Sara F. Azimi

  • Mackenzie R. Keintz

  • Molly M. Miller

  • Mark E. Rupp

  • Jasmine R. Marcelin

  • June 3, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    University of Nebraska Medical Center
    University of Nebraska Medical Center

    Omaha, NE

    Key Differentiators

    • Infectious Disease

  • #2

    Nebraska Medicine
    Nebraska Medicine

    Omaha, NE

    Key Differentiators

    • Infectious Disease

  • #3

    Second Xiangya Hospital of Central South University
    Second Xiangya Hospital of Central South University

    Changsha, Hunan

    Key Differentiators

    • Infectious Disease

  • #4

    University of Salerno
    University of Salerno

    Salerno, Campania

    Key Differentiators

    • Infectious Disease

  • #5

    Liverpool University Hospitals NHS Foundation Trust
    Liverpool University Hospitals NHS Foundation Trust

    Liverpool, England

    Key Differentiators

    • Infectious Disease

Original Source(s)

Practical vs Recent Clinical Trial Use Of Dalbavancin

  • by Sarah A. Uhm, Bryan T. Alexander, Elizabeth R. Lyden, Nicolas Cortes-Penfield, Harlan R. Sayles, Sara F. Azimi, Mackenzie R. Keintz, Molly M. Miller, Mark E. Rupp, Jasmine R. Marcelin

  • June 3, 2026

Related Content

Efficacy and safety of ozone autohemotherapy for zoster-associated pain: a meta-analysis and trial sequential analysis

The Sm29 antigen differentially shapes transcriptomic and regulatory landscapes across reactional forms of leprosy

Gut microbiota and sepsis-associated acute kidney injury: a narrative review